Chinese authorities have indicted British and US investigators hired by GlaxoSmithKline (GSK) on charges of illegally obtaining and selling private information, Chinese media reported yesterday, as the Briton accused the pharmaceutical company of misleading and using him.
Prosecutors in Shanghai filed charges of illegally obtaining and selling private information against British investigator Peter Humphrey and his wife, Yingzeng Yu (虞英曾), a US citizen, at the city’s No. 1 Intermediate People’s Court, the Xinhua news agency report said.
The move paves the way for the couple to stand trial.
The reported added it was the first time foreigners had faced such charges in China.
Humphrey, 58, and Yu, 61, are part of an industry of investigators who help corporate clients screen potential partners and employees or watch for embezzlement or other employee misconduct.
The couple’s arrest last year coincided with a Chinese investigation of accusations that GlaxoSmithKline paid bribes to doctors and officials to use its medications.
Glaxo said it hired Yu and Humphrey last year to investigate a security breach involving a top manager.
The indictment received prominent coverage in China. Reports by state broadcaster China Central Television (CCTV) showed Humphrey and his wife being separately interviewed by Chinese reporters.
In CCTV’s footage, they were shown seated and wearing the orange vests typical of detainees, as they spoke to reporters.
According to Xinhua, the couple are accused of illegally selling a “huge amount” of personal information on Chinese citizens, including home addresses, information about family members, details about real estate and vehicles and records of travelers entering and leaving the country.
The investigators are accused of obtaining such information by illegally buying it from others as well as with hidden cameras or by following people, Xinhua said.
Yu and Humphrey would compile the information gathered on the subjects of their investigations and sell the reports to clients that were mainly multinational companies based in China such as GSK China, the report said.
They ran the Shanghai-based corporate intelligence and consulting firm ChinaWhys Ltd.
In Chinese media reports yesterday, Humphrey said he had been contacted in April last year by GSK’s then-China manager, Mark Reilly, who wanted him to find out who had leaked allegations of bribery at the company to Chinese authorities and senior executives at the firm.
Reilly is at the center of a major investigation into corruption in China’s medical industry.
In May, he was accused of leading a sprawling scheme to bribe doctors and hospitals to use GSK’s drugs. Reilly’s case has been turned over to prosecutors.
Humphrey said on state television that he found out during his investigation that the bribery claims were true and if he had known that earlier he would not have carried out the probe.
Humphrey said he felt “betrayed and used” by the pharmaceutical firm.
GSK did not immediately respond to e-mailed requests for comment.
The British embassy in Beijing said it was providing consular help to Humphrey and his family and have told Chinese authorities they would like to attend the trial, which the court has said is to be closed. A trial date hasn’t been announced yet.
“We have made clear to the Chinese authorities that we would like Embassy staff to attend the trial and the need for a transparent and fair process,” the embassy said in an e-mailed response to questions.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
ARTIFICIAL INTELLIGENCE: The chipmaker last month raised its capital spending by 28 percent for this year to NT$32 billion from a previous estimate of NT$25 billion Contract chipmaker Powerchip Semiconductor Manufacturing Corp (力積電子) yesterday launched a new 12-inch fab, tapping into advanced chip-on-wafer-on-substrate (CoWoS) packaging technology to support rising demand for artificial intelligence (AI) devices. Powerchip is to offer interposers, one of three parts in CoWoS packaging technology, with shipments scheduled for the second half of this year, Powerchip chairman Frank Huang (黃崇仁) told reporters on the sidelines of a fab inauguration ceremony in the Tongluo Science Park (銅鑼科學園區) in Miaoli County yesterday. “We are working with customers to supply CoWoS-related business, utilizing part of this new fab’s capacity,” Huang said, adding that Powerchip intended to bridge
Microsoft Corp yesterday said that it would create Thailand’s first data center region to boost cloud and artificial intelligence (AI) infrastructure, promising AI training to more than 100,000 people to develop tech. Bangkok is a key economic player in Southeast Asia, but it has lagged behind Indonesia and Singapore when it comes to the tech industry. Thailand has an “incredible opportunity to build a digital-first, AI-powered future,” Microsoft chairman and chief executive officer Satya Nadella said at an event in Bangkok. Data center regions are physical locations that store computing infrastructure, allowing secure and reliable access to cloud platforms. The global embrace of AI
Qualcomm Inc, the world’s biggest seller of smartphone processors, gave an upbeat forecast for sales and profit in the current period, suggesting demand for handsets is increasing after a two-year slump. Revenue in the three months ended in June will be US$8.8 billion to US$9.6 billion, the company said in a statement Wednesday. Excluding certain items, earnings will be US$2.15 to US$2.35 a share. Analysts had projected sales of US$9.08 billion and earnings of US$2.16 a share. The outlook signals that the smartphone market has begun to bounce back, tracking with Qualcomm’s forecast that demand would gradually recover this year. The San